Deep Learning in Drug Discovery and Diagnostics, 2017 – 2035

I was recently contacted by Gaurav Chaudhary, who is the CEO of Roots Analysis, a firm that provide market research and consulting for the pharmaceutical industry. It turns out that Wildcard Pharmaceutical Consulting was mentioned in their report: Deep Learning in Drug Discovery and Diagnostics, 2017 – 2035.

I don’t know rootsanalysis.com or have any idea about the quality of their reports. If you have any experience with their work, please let me know in the comments below.